Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Swann

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Advances in Experimental Medicine and Biology|December 29, 2006
Innate tumor immune surveillanceMark J Smyth, Jeremy Swann, Yoshihiro Hayakawa
Bioinformatics (Oxford, England)|May 13, 2022
ReadItAndKeep: rapid decontamination of SARS-CoV-2 sequencing readsMartin Hunt, Jeremy Swann, Bede Constantinides, et al.
Open Biology|February 24, 2021
Evolution of thymopoietic microenvironmentsRyo Morimoto, Jeremy Swann, Anja Nusser, et al.
Immunology and Cell Biology|June 10, 2004
Regulation of antitumour immunity by CD1d-restricted NKT cellsJeremy Swann, Nadine Y Crowe, Yoshihiro Hayakawa, et al.
The Journal of Experimental Medicine|September 1, 2005
NKG2D function protects the host from tumor initiationMark J Smyth, Jeremy Swann, Erika Cretney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancerMark J Smyth, Michele W L Teng, Jeremy Swann, et al.
Genome Research|September 3, 2020
High precision <i>Neisseria gonorrhoeae</i> variant and antimicrobial resistance calling from metagenomic Nanopore sequencingNicholas D Sanderson, Jeremy Swann, Leanne Barker, et al.
The Journal of Experimental Medicine|November 17, 2004
NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancerMark J Smyth, Jeremy Swann, Janice M Kelly, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2025
Lamprey <i>FOXN1</i> rescues the block of thymic epithelial cell development in the mouse <i>Foxn1</i>-deficient thymic rudimentRyo Morimoto, Gaoqun Zhang, Oliver S Thomas, et al.
The Journal of Experimental Medicine|December 21, 2005
A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillanceMasaki Terabe, Jeremy Swann, Elena Ambrosino, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|December 29, 2006
Innate tumor immune surveillanceMark J Smyth, Jeremy Swann, Yoshihiro Hayakawa
Bioinformatics (Oxford, England)|May 13, 2022
ReadItAndKeep: rapid decontamination of SARS-CoV-2 sequencing readsMartin Hunt, Jeremy Swann, Bede Constantinides, et al.
Open Biology|February 24, 2021
Evolution of thymopoietic microenvironmentsRyo Morimoto, Jeremy Swann, Anja Nusser, et al.
Immunology and Cell Biology|June 10, 2004
Regulation of antitumour immunity by CD1d-restricted NKT cellsJeremy Swann, Nadine Y Crowe, Yoshihiro Hayakawa, et al.
The Journal of Experimental Medicine|September 1, 2005
NKG2D function protects the host from tumor initiationMark J Smyth, Jeremy Swann, Erika Cretney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancerMark J Smyth, Michele W L Teng, Jeremy Swann, et al.
Genome Research|September 3, 2020
High precision <i>Neisseria gonorrhoeae</i> variant and antimicrobial resistance calling from metagenomic Nanopore sequencingNicholas D Sanderson, Jeremy Swann, Leanne Barker, et al.
The Journal of Experimental Medicine|November 17, 2004
NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancerMark J Smyth, Jeremy Swann, Janice M Kelly, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2025
Lamprey <i>FOXN1</i> rescues the block of thymic epithelial cell development in the mouse <i>Foxn1</i>-deficient thymic rudimentRyo Morimoto, Gaoqun Zhang, Oliver S Thomas, et al.
The Journal of Experimental Medicine|December 21, 2005
A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillanceMasaki Terabe, Jeremy Swann, Elena Ambrosino, et al.
Pageof 3